Myomo Announces First Quarter Financial Results Release Date of May 8, 2024

Published:

Myomo, Inc. to Report First Quarter 2024 Financial Results on May 8, 2024

Myomo, Inc. to Report First Quarter 2024 Financial Results on May 8th

BOSTON, May 01, 2024– Myomo, Inc. (NYSE American: MYO), a leading wearable medical robotics company specializing in providing increased functionality for individuals with neurological disorders and upper-limb paralysis, has announced that it will be releasing its financial results for the first quarter ended March 31, 2024, on May 8, 2024.

The company will be hosting a conference call on the same day, Wednesday, May 8, 2024, at 4:30 p.m. ET. The call will feature prepared remarks by Paul R. Gudonis, chairman and chief executive officer, and David Henry, chief financial officer.

Participants are encouraged to pre-register for the conference call using the provided link. Pre-registered callers will receive a conference passcode and unique PIN for immediate access to the call, bypassing the live operator. For those unable to pre-register, dial-in options are available for both U.S. and international participants. Additionally, a webcast of the call can be accessed on Myomo’s Investor Relations page.

A replay of the webcast will be available approximately one hour after the live conference call, with a dial-in replay option available until May 22, 2024.

Myomo, Inc. is a pioneer in wearable medical robotics, offering innovative solutions to improve arm and hand function for individuals with neurological disorders and upper limb paralysis. The company’s MyoPro product line includes a powered upper limb orthosis designed to support and restore function to weakened or paralyzed arms, enabling patients to perform daily activities and tasks.

Headquartered in Boston, Massachusetts, Myomo has a team of sales and clinical professionals across the U.S. and international representatives. For more information, visit www.myomo.com.

Contact information for Myomo:
For Myomo: [email protected]
Investor Relations:
Kim Sutton Golodetz
LHA Investor Relations
212-838-3777
[email protected]

Source: https://www.businesswire.com/news/home/20240501128303/en/

Related articles

Recent articles